Research Articles
Pharmaceutical Gene Medicines: Healing from Within Local and Systemic Therapy
Explore the revolutionary world of pharmaceutical gene medicines, comparing localized and systemic approaches for treating genetic disorders and chronic conditions.
Statistics and Cancer Biomarkers: The Mathematical Hunt for Melanoma's Telltale Signs
Explore how statistical approaches and biomarker research are revolutionizing melanoma prognosis and personalized treatment approaches.
The Hereditary Code: The High-Stakes Race to Unlock the Secrets of Breast Cancer
Discover the fascinating story of BRCA gene discovery and how biotech companies revolutionized our understanding of hereditary breast cancer.
Tiny Patients, Giant Leaps: Tailoring Medical Marvels for Children
Exploring how Paediatric Investigation Plans (PIPs) ensure advanced therapies are safely developed for children through rigorous scientific protocols.
Targeting Aurora2 Kinase: A Structural Blueprint to Combat Cancer
Discover how structural bioinformatics is revolutionizing cancer treatment through targeted Aurora2 kinase inhibition, from computational models to smart drug design.
The Hidden Power of Ferns: Ancient Plants, Modern Cures
Explore how pteridophytes - ancient ferns and their allies - are emerging as promising sources for alternative medicines in treating contemporary human ailments.
The Cellular Postcode: Cracking the Address of a Key Protein
Discover how scientists corrected the molecular address of MSP58 protein, revealing crucial insights into cellular organization and cancer development.
Immune Profiling: The New Compass for Cancer Drug Development
Explore how immune profiling technologies are revolutionizing cancer drug development and personalized immunotherapy treatments.
Decoding Cancer's Blueprint: How Math Reveals Hidden Biological Networks
Discover how joint matrix tri-factorization is revolutionizing cancer research by revealing hidden biological networks across multiple genomic data types.
Unlocking New Hope in Blood Cancer Treatment: The Voruciclib Story
Exploring the Phase 1 clinical trial of voruciclib, a novel CDK9 inhibitor for relapsed/refractory AML and B-cell malignancies